We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Mobile Cardiac Telemetry Proves Cost-Effective

By HospiMedica International staff writers
Posted on 06 Jan 2014
Print article
A new study shows that monitoring patients with mobile cardiac telemetry (MCT) is better than using Event or Holter monitors.

Researcher at Bayser Consulting (Skokie, IL, USA) conducted a retrospective analysis of claims data from January 2007 to September 2011, pertaining to 200,000+ patients, of whom 14,000 used MCT only, 54,000 used an Event monitor only, and 163,000 used a Holter monitor only. The researchers used a pair-wise pre/post-test-control methodology to ensure that control patients were similar to test patients with regard to age, geographic location, type of cardiovascular diagnosis both in the inpatient and outpatient settings, and the cardiovascular drug class the patient used.

The results showed that the diagnostic yield of patients monitored with MCT is 61%, significantly higher than that of patients that use the Event monitor (23%), or the Holter monitor (24%). In addition, significantly more patients naive to antiarrhythmic drugs initiated therapy after monitoring with the MCT (61%), compared with 39% for patients that used the Event monitor, and 43% for patients that use the Holter monitor. Significant inpatient cardiovascular savings were found for patients that underwent ablation, coronary artery bypass graft (CABG), and valve septa procedures. The study was published on December 19, 2013, in Medical Devices: Evidence and Research.

“Given the superior outcome of MCT regarding both patient care and hospital savings, hospitals only stand to gain by enforcing protocols that favor the MCT system over the Event or the Holter monitor,” concluded study authors Jean-Patrick Tsang, PhD, MBA, and analyst Shunmugam Mohan.

The MCT is a small sensor and monitor developed by Cardionet (Pennsylvania, PA, USA) that patients wear daily. When a cardiac event occurs, the system instantaneously transmits the data to a center for analysis and response, which in turn sends a report along with graphs and trends to the patient's physician for diagnosis and therapy management.

Related Links:

Bayser Consulting
Cardionet


Gold Member
12-Channel ECG
CM1200B
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Surgical Table
STERIS 5085 SRT

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more